Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma
Author(s)
Type
Journal Article
Date Issued
2022-06-24
Date Acceptance
2022-05-30
Citation
Oncogene, 2022, 41 (26), pp.3510-3510
ISSN
0950-9232
Publisher
Springer Nature [academic journals on nature.com]
Start Page
3510
End Page
3510
Journal / Book Title
Oncogene
Volume
41
Issue
26
Copyright Statement
© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Identifier
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000802880500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
Subjects
Biochemistry & Molecular Biology
Cell Biology
Genetics & Heredity
Life Sciences & Biomedicine
Oncology
Science & Technology
Publication Status
Published
Date Publish Online
2022-05-30